320 related articles for article (PubMed ID: 21920426)
21. State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy.
Ganapathi SB; Kester M; Elmslie KS
Am J Physiol Cell Physiol; 2009 Apr; 296(4):C701-10. PubMed ID: 19244476
[TBL] [Abstract][Full Text] [Related]
22. Allocryptopine and benzyltetrahydropalmatine block hERG potassium channels expressed in HEK293 cells.
Lin K; Liu YQ; Xu B; Gao JL; Fu YC; Chen Y; Xue Q; Li Y
Acta Pharmacol Sin; 2013 Jun; 34(6):847-58. PubMed ID: 23524574
[TBL] [Abstract][Full Text] [Related]
23. Frequency- and state-dependent blockade of human ether-a-go-go-related gene K+ channel by arecoline hydrobromide.
Zhao XY; Liu YQ; Fu YC; Xu B; Gao JL; Zheng XQ; Lin M; Chen MY; Li Y
Chin Med J (Engl); 2012 Mar; 125(6):1068-75. PubMed ID: 22613533
[TBL] [Abstract][Full Text] [Related]
24. Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: Cisapride versus dofetilide.
Milnes JT; Witchel HJ; Leaney JL; Leishman DJ; Hancox JC
J Pharmacol Toxicol Methods; 2010; 61(2):178-91. PubMed ID: 20172036
[TBL] [Abstract][Full Text] [Related]
25. Aconitine blocks HERG and Kv1.5 potassium channels.
Li Y; Tu D; Xiao H; Du Y; Zou A; Liao Y; Dong S
J Ethnopharmacol; 2010 Aug; 131(1):187-95. PubMed ID: 20600762
[TBL] [Abstract][Full Text] [Related]
26. The action of a novel fluoroquinolone antibiotic agent antofloxacin hydrochloride on human-ether-à-go-go-related gene potassium channel.
Guo J; Han SN; Liu JX; Zhang XM; Hu ZS; Shi J; Zhang LR; Zhao ZZ; Zhang Z
Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):643-9. PubMed ID: 20662825
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of inhibition by olanzapine of cloned hERG potassium channels.
Lee HJ; Choi JS; Hahn SJ
Neurosci Lett; 2015 Nov; 609():97-102. PubMed ID: 26484507
[TBL] [Abstract][Full Text] [Related]
28. Protriptyline block of the human ether-à-go-go-related gene (HERG) K+ channel.
Jo SH; Hong HK; Chong SH; Choe H
Life Sci; 2008 Jan; 82(5-6):331-40. PubMed ID: 18191158
[TBL] [Abstract][Full Text] [Related]
29. Effects of phosphodiesterase (PDE) inhibitors on human ether-a-go-go related gene (hERG) channel activity.
Yunomae K; Ichisaki S; Matsuo J; Nagayama S; Fukuzaki K; Nagata R; Kito G
J Appl Toxicol; 2007; 27(1):78-85. PubMed ID: 17146843
[TBL] [Abstract][Full Text] [Related]
30. Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action.
Vonderlin N; Fischer F; Zitron E; Seyler C; Scherer D; Thomas D; Katus HA; Scholz EP
Drug Des Devel Ther; 2015; 9():867-77. PubMed ID: 25733807
[TBL] [Abstract][Full Text] [Related]
31. The effects of a novel anti-arrhythmic drug, acehytisine hydrochloride, on the human ether-a-go-go related gene K channel and its trafficking.
Huang X; Yang Y; Zhu J; Dai Y; Pu J
Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):145-54. PubMed ID: 19143746
[TBL] [Abstract][Full Text] [Related]
32. Mechanism and pharmacological rescue of berberine-induced hERG channel deficiency.
Yan M; Zhang K; Shi Y; Feng L; Lv L; Li B
Drug Des Devel Ther; 2015; 9():5737-47. PubMed ID: 26543354
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action.
Thomas D; Hammerling BC; Wu K; Wimmer AB; Ficker EK; Kirsch GE; Kochan MC; Wible BA; Scholz EP; Zitron E; Kathöfer S; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
Br J Pharmacol; 2004 Jun; 142(3):485-94. PubMed ID: 15148258
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives.
Qian JQ
Acta Pharmacol Sin; 2002 Dec; 23(12):1086-92. PubMed ID: 12466045
[TBL] [Abstract][Full Text] [Related]
35. Curcumin inhibits hERG potassium channels in vitro.
Hu CW; Sheng Y; Zhang Q; Liu HB; Xie X; Ma WC; Huo R; Dong DL
Toxicol Lett; 2012 Jan; 208(2):192-6. PubMed ID: 22101212
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the HERG K+ channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656.
Ridley JM; Milnes JT; Duncan RS; McPate MJ; James AF; Witchel HJ; Hancox JC
FEBS Lett; 2006 Apr; 580(8):1999-2005. PubMed ID: 16542653
[TBL] [Abstract][Full Text] [Related]
37. The human ether-a-go-go-related gene (hERG) current inhibition selectively prolongs action potential of midmyocardial cells to augment transmural dispersion.
Yasuda C; Yasuda S; Yamashita H; Okada J; Hisada T; Sugiura S
J Physiol Pharmacol; 2015 Aug; 66(4):599-607. PubMed ID: 26348084
[TBL] [Abstract][Full Text] [Related]
38. A novel missense mutation causing a G487R substitution in the S2-S3 loop of human ether-à-go-go-related gene channel.
Kinoshita K; Yamaguchi Y; Nishide K; Kimoto K; Nonobe Y; Fujita A; Asano K; Tabata T; Mori H; Inoue H; Hata Y; Fukurotani K; Nishida N
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1246-53. PubMed ID: 22764740
[TBL] [Abstract][Full Text] [Related]
39. Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy.
Kawakami K; Nagatomo T; Abe H; Kikuchi K; Takemasa H; Anson BD; Delisle BP; January CT; Nakashima Y
Br J Pharmacol; 2006 Mar; 147(6):642-52. PubMed ID: 16314852
[TBL] [Abstract][Full Text] [Related]
40. Bertosamil blocks HERG potassium channels in their open and inactivated states.
Zitron E; Karle CA; Wendt-Nordahl G; Kathöfer S; Zhang W; Thomas D; Weretka S; Kiehn J
Br J Pharmacol; 2002 Sep; 137(2):221-8. PubMed ID: 12208779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
